Artemis Medicare Artemis Medicare Services Ltd.NSE:ARTEMISMEDMicrocap_Investorπ― STOCK TO WATCH WEEKLY R4 MOMENTUM BREAKOUT SETUP βΉ347β350 β βΉ548 β βΉ779 A hospital expansion + strong profit growth + momentum setup appearing on my Weekly R4 Momentum Breakout Scanner. π₯ ARTEMIS MEDICARE SERVICES LTD NSE: ARTEMISMED π TRADE LEVELS π’ Buy Zone: βΉ347β350 π Breakout Zone: βΉ347 π΄ Stop Loss: βΉ258 π― Target 1: βΉ548 π Target 2: βΉ779 π₯ WHY ARTEMIS MEDICARE? β’ Strong Q1 FY27 performance: Consolidated revenue from operations reached βΉ287.32 Cr, up 12.69% YoY. ξ β’ PAT acceleration: Q1 FY27 PAT jumped 48.33% YoY to βΉ31.44 Cr, with EPS rising 46.67% YoY. ξ β’ Margin improvement: Q1 FY27 EBITDA margin was around 21.5%, showing improvement in operating profitability. ξ β’ Large expansion runway: Artemis has approved Tower IV with 200+ additional beds, focused on quaternary paediatric care and advanced gynaecology/women's health. ξ β’ Established healthcare platform: Artemis operates a 400+ bed multispecialty hospital in Gurgaon and is JCI/NABH accredited. ξ β’ FY26 was already a strong base: Consolidated FY26 revenue from operations was βΉ1,081 Cr, with PAT of βΉ103.72 Cr, versus βΉ82.18 Cr in FY25. ξ π WHY IT CAUGHT MY ATTENTION π βΉ347 is the key technical trigger on my R4 scanner. π Q1 revenue continues to grow double-digit YoY. π PAT growth is substantially faster than revenue growth. π Operating margins have improved. π 200+ new beds provide a potential next phase of capacity-led growth. π The company's healthcare platform is already established rather than being a purely speculative expansion story. β οΈ IMPORTANT This is still a high-risk momentum setup. The planned Tower IV expansion requires approximately βΉ160β180 Cr of investment, with internal accruals and debt financing, so execution and balance-sheet discipline need monitoring. ξ Also, Q1FY27 capacity utilisation was around 65.7%, meaning the success of the additional capacity will depend on successfully ramping specialised services. Risk Defined. Reward Visible. β οΈ This content is for educational purposes only and not investment advice. Please do your own due diligence before making any investment decisions. Β© 20K Microcap Investing | R4 Momentum Desk #ArtemisMedicare #ARTEMISMED #HospitalStocks #HealthcareStocks #MomentumStocks #BreakoutStocks #IndianStocks #R4Momentum #StockToWatch